MBLX Financial Facts
Research and development expenses, including cost of revenue: 1.55MGrant revenue: 473K
See Full Income Statement
Commitments and contingencies (Note 11): 0
Other long-term liabilities: 1.97M
See Full Balance Sheet
Metabolix, Inc. (MBLX) Earnings
|
Expand Research on MBLX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +9.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +1.9% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/9/16  |
 |
Q316 | -$0.05 | N/A | N/A | $500K | $300K | N/A |  | | Details |
| 3/29/16 |
|
Q415 | -$0.22 | N/A | N/A | $496K | $856K | N/A | | | Details |
| 11/10/15 |
|
Q315 | -$0.22 | N/A | N/A | N/A | $744K | N/A | | | Details |
| 8/12/15 |
|
Q215 | -$0.26 | N/A | N/A | $700K | $699K | N/A | | | Details |
| 5/13/15 |
|
Q115 | -$0.04 | -$0.04 | $0.00 | $645K | $620K | N/A | | | Details |
| 3/19/15 |
|
Q414 | -$0.05 | -$0.09 | +$0.04 | $856K | $630K | N/A | | | Details |
| 7/31/13 |
|
Q213 | -$0.23 | -$0.20 | -$0.03 | $822K | $1.57M | N/A | | | Details |
| 5/8/13 |
|
Q113 | -$0.20 | -$0.22 | +$0.02 | $1.9M | $1.43M | N/A | | | Details |
